Ending the reign of short-acting β2-agonists in Australia?
Price, D., Jenkins, C., Hancock, K., Vella, R., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S. Z., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Novic, D., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Willet, B., Bateman, E. D., Beekman, M., Stewart, D.
Demographic and Clinical Characteristics of Patients with Severe Asthma in the Asian Pacific Region: data from the International Severe Asthma Registry (ISAR)
Lyu, J., Rhee, C. K., Tran, T. N., Katial, R., Martin, N., Peters, M., Denton, E., Upham, J. W., Bardin, P. G., Cochrane,, B., Middleton, P. G., Reynolds, P. M., Perng, D. W., Wang, H., Sheu, C., Tsai, M., Wan-Chun Huang, E., Chien, Y., Hsu, J., Fu, P., Lin, C., Lin, S., Shen, S., Liu, S., Lee, K., Chiu, K., Lin, H., Lin, M., Chou, C., Salvi, S., Cho, Y. S., Yoo, K. H., Iwanaga, T., Tohda, Y., Fujimoto, H., Tanaka, H., Nogami, K., Sekiya, K., Matsunaga, M., Soichiro, H., Fujisawa, T., Nagano, T., Kobayashi, T., Oguma, T., Nishimura, Y., Murray, R. B., Bulathsinhala, L., Joshi, I., Eleangovan, N., Skinner, D., Carter, V., Price, C., Price, D.
Dupilumab sustains improvements in clinical efficacy and reductions in OCS use in patients with severe, OCS-dependent asthma: LIBERTY ASTHMA TRAVERSE study
Park, H. Y., Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Ending the reign of short-acting β2-agonists in Australia?
Price, D., Jenkins, C., Hancock, K., Vella, R., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Novic, D., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Willet, B., Bateman, E. D.
The association of short acting β2-agonist overuse with asthma control and severe exacerbations: an Australian perspective
Price, D., Jenkins, C., Hancock, K., Hancock, K., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Bateman, E. D.
Effect of stepping up to high-dose inhaled corticosteroids in patients with asthma: UK Database Study
Pavord, I. D., Tran, T. N., Jones, R., Nuevo, J., van den Berge, M., Brusselle, G., Menzies-Gow, A., Skinner, D., Carter, V., Kocks, J. W. H., Price, D.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 2, pp. 532-543
Sustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
An observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
Heatley, H., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Skinner, D., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
Clinical recommendations for dry powder inhaler use in the management of COPD in primary care
Leving, M., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Román-Rodríguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Usmani, O., Kocks, J.
npj Primary Care Respiratory Medicine, vol. 32, 59